Synthetic Biologics Inc. (SYN): Analysis on simple moving average


Synthetic Biologics Inc. (AMEX:SYN) changes shares on Monday trading session, with a change of 16.33% or $0.08 shares. The trading starts at $0.53 and closed at $0.49 throughout the day. The trading session low price was $0.50 and day high was $0.58 on Monday, June 22. After the session, the Healthcare sector daily volume shifted to 1.64 million while its average volume is 403.64K. In other hand, the SYN market cap reached to $10.82M. While, its current target price is $0.57 according to WSJ.

Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 33.65% and up 77.68% for month. Its quarterly performance was 81.53% above, while its half year performance is up 19.62%. SYN yearly performance stood at positive 4.43% and rise 12.45% for year-to-date. Current recommendation for Synthetic Biologics Inc. is 2.00.

Earnings per share or EPS is an important financial measure, which defines the profitability of a company. SYN EPS (TTM) for 12-month is -0.93. EPS for this year is 75.90%, while for the next year its value is -0.41. Its EPS Q/Q reached 20.90%. It has an EPS of 38.60% up for past five years.

Let’s take a look on the analyst recommendations on SYN for the current month and previous month. For the current month, 2 of 2 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $1.25-$1.50. Average target price for SYN was reached at $1.38.

The insider ownership moved to 0.13% and institutional holding shifted to 7.40%.

The company posted an EPS (TTM) of -0.93. According to the most recent quarter report on (Jun 2020), 2 analysts estimated an average EPS of -0.16, while -0.22 EPS posted a year ago period. Analyst Estimated EPS for SYN published in the report was -0.18–0.14 during the same period. Comparing with last year, the average estimated EPS was -0.22 which is lower than -0.17 which was posted for recent quarter EPS.

A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for SYN rise 34.96% for period of 200 days. SMA for 50 days was 54.22% which is showing green signal, while SMA-20 was 36.04%. The moving average value for Synthetic Biologics Inc. (SYN) is 0.4192 and 0.3883 for 200 and 50 days respectively.

Let’s take a look on the insider transactions, in which multiple shareholders are showing interest in SYN stock. On Aug 23, SHALLCROSS STEVEN A, CEO and CFO, bought 50,000 trading shares at the cost of $0.42, which valued at 20785.0.